Tezspire 210 MG/1.91 ML pen 1.91ML
Ended Awarded Last action
- Contract number
- SPE2DR26F21KC
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $24,698
Award facts
- Contract value 100% obligated
- $24,697.80 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $24.7K delivery order to AmerisourceBergen Drug Corp on January 28, 2026, for the supply of Tezspire 210 mg/1.91 mL pen injectors. This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of February 19, 2026. The place of performance is the vendor's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a single-award IDC valued at $999,999,999.00 through December 2026 that serves as the primary vehicle for pharmaceutical and medical supply distribution to support military healthcare programs globally.
AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major pharmaceutical distributor that serves as a critical vendor for federal medical procurement, particularly for Department of Defense and Veterans Affairs healthcare systems. The company's extensive federal contract portfolio encompasses a comprehensive range of medications and medical supplies across multiple therapeutic domains, including specialty pharmaceuticals, vaccines, and medical devices. The Tezspire delivery order reflects the company's ongoing role in supplying prescription medications to support military treatment facilities and veteran healthcare programs through the DLA's pharmaceutical supply chain.
Quick answers
Who was awarded contract SPE2DR26F21KC?
SPE2DR26F21KC was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 28, 2026.
How much is contract SPE2DR26F21KC worth?
The government has obligated $24,698 on SPE2DR26F21KC.
Is contract SPE2DR26F21KC an order under another contract?
Yes. SPE2DR26F21KC is a delivery order under SPE2DR25D3301, an indefinite delivery contract.
Was contract SPE2DR26F21KC competed?
The extent of competition for SPE2DR26F21KC was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award